First post on EMV for which you have a 'buy' sentiment and, despite all the amazing progress with EMV over the past year, the post is about how a competitor is 'a great Australian innovation'. That is weird!
We all know that MX1 has a minimised CT scanner under development that could be used in ambulances but we also know that the Company is struggling and what would be interesting here would be to know how the Company is coping with its difficulties, the implications going forward and exactly where, in the development cycle, the stroke scanning device is compared to EMV's Gen 2 device. Did the program touch on any of that?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)